Any current/future capex/capital investment/strategic investment?

The company is focused on investing behind brands and strategic priorities to drive competitive volume-led growth. Continued investment in capacity expansion and brand strengthening is emphasized to capitalize on medium and long-term growth opportunities. Investments in cold chain infrastructure have been incremental over past decades; further increments are expected as business demands. There is strong R&D capability supported by Unilever's global resources; investments in innovation (e.g., Stratos technology) have been made. In health and wellbeing categories like OZiva and Wellbeing Nutriti

Future growth expectations in sales/revenue/volumes?

Expectation of stable demand trends with no further acceleration in growth near-term. Underlying sales growth was 2%-3%, with underlying volume growth of 3%. Anticipate low single-digit price growth if commodity prices remain steady. Volume-led competitive growth is a core focus to improve market share. Growth is higher in premium segments, especially in beauty and e-commerce channels, with premium beauty portfolio growing at high double digits (~30% GSV growth). Expect gradual recovery in volume growth for lagging categories like soaps and mass skin care over the next few quarters.

Future growth expectations in earnings/operating earnings/profits/EPS?

Underlying sales growth expected around low single-digit range in near term; volume growth expected around 3-4% over medium term. EBITDA margin targeted to be maintained at current healthy levels (~23.8%), with small fluctuations possible. PAT growth expected to be modest; intrinsic profit after tax grew by 2% in the recent quarter while reported PAT declined due to tax base effects. Price growth likely to resume after a flat quarter, with low single-digit price increases expected if commodity prices remain stable. Focus on volume-led competitive growth across channels, investing behin

Hind. UnileverQ2 FY25Diversified FMCG

Hind. Unilever Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,836P/E: 41.4Market Cap: ₹4.6L CrSector: Diversified FMCG

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Expectation of stable demand trends with no further acceleration in growth near-term.
Underlying sales growth was 2%-3%, with underlying volume growth of 3%.
Anticipate low single-digit price growth if commodity prices remain steady.
Volume-led competitive growth is a core focus to improve market share.
Growth is higher in premium segments, especially in beauty and e-commerce channels, with premium beauty portfolio growing at high double digits (~30% GSV growth).
Expect gradual recovery in volume growth for lagging categories like soaps and mass skin care over the next few quarters.
Focus on investing behind brands and strategic priorities to drive competitive superiority and volume growth.
Expect volumes to trend back to natural organic levels of 3%-4% over the longer term.
Emphasis on portfolio premiumization with growth in modern trade, e-commerce, and premium categories.
Long-term outlook remains positive due to low per capita consumption and market development efforts.

Margin guidance

Category 3

Underlying sales growth expected around low single-digit range in near term; volume growth expected around 3-4% over medium term.
EBITDA margin targeted to be maintained at current healthy levels (~23.8%), with small fluctuations possible.
PAT growth expected to be modest; intrinsic profit after tax grew by 2% in the recent quarter while reported PAT declined due to tax base effects.
Price growth likely to resume after a flat quarter, with low single-digit price increases expected if commodity prices remain stable.
Focus on volume-led competitive growth across channels, investing behind brands, capacity, and portfolio transformation in high-growth, premium segments.
Long-term growth outlook remains positive due to low per capita consumption and secular premiumization trends.
Market demand trends are stable but recovery pace is watchfully monitored.
Margin and profit sustainability underpinned by productivity programs and dynamic cost management.

See what Hind. Unilever management said on margin guidance — free account, 30 seconds.

Fundraise plans

The provided transcript from the Hindustan Unilever Limited (HUL) September Quarter 2024 Earnings call does not mention any current or future plans for fundraising through debt or equity. Key points: - No explicit discussion regarding issuing new debt or equity. - No announcements or indications of capital raising activities. - Focus remains on managing business dynamically, investing in brands, capacity, and maintaining healthy EBITDA margins. - Discussions mainly relate to portfolio transformation, market conditions, and operational strategy. - Separation of ice cream business is mentioned with options being sale or demerger, but no firm decision or fundraising plan linked to it is disclosed. Therefore, there is no mention or update on new fundraising through debt or equity in the provided text.

Order book

The earnings call transcript of Hindustan Unilever Limited for the September Quarter 2024 does not explicitly mention any details related to current or expected orderbooks or pending orders. The discussion primarily focuses on market share, channel strategies (general trade, modern trade, e-commerce, quick commerce), volume and price growth, margin outlook, competitive positioning, and channel profitability. Key relevant points: - General trade (kirana) accounts for about two-thirds of business and remains priority. - Modern trade is growing double digits with increasing share. - E-commerce comprises around 6-7% of business and is growing faster, quick commerce is a small part. - No mention of quantitative orderbook or pending order details. - Focus remains on competitive volume-led growth, portfolio transformation, and channel-specific market share improvement. Hence, there is no disclosed information on orderbook or pending orders in the call.

See what Hind. Unilever management said on order book — free account, 30 seconds.

Capex plans

Yes

The company is focused on investing behind brands and strategic priorities to drive competitive volume-led growth.
Continued investment in capacity expansion and brand strengthening is emphasized to capitalize on medium and long-term growth opportunities.
Investments in cold chain infrastructure have been incremental over past decades; further increments are expected as business demands.
There is strong R&D capability supported by Unilever's global resources; investments in innovation (e.g., Stratos technology) have been made.
In health and wellbeing categories like OZiva and Wellbeing Nutrition, investments are being made to scale up these budding segments.
A&P (Advertising & Promotion) spends remain high, averaging about 10.5%, with a shift toward digital media (now ~45% of working media).
Capex on formats such as Q-commerce and emerging demand spaces is ongoing, reflecting a strategic push into high-growth areas.

Track Hind. Unilever — get its next earnings analysis in your feed

How does Hind. Unilever rank vs peers in Diversified FMCG?

Pro feature

ThisHind. Unilever

Rev 4Mar 3

See where Hind. Unilever sits in Diversified FMCGSee which companies these are, and every other name in the sector.Open rankings

How does Hind. Unilever rank in Diversified FMCG?

Compare Hind. Unilever against every Diversified FMCG company (Q2 FY25) on revenue, margins and earnings-call signals.

View Diversified FMCG leaderboard →

What Hind. Unilever's management said in earlier quarters

Others in Diversified FMCG this season

ITC Ltd (Q2 FY25)
1,457 crore (versus Rs. Key concall takeaways from ITC Ltd's Q2 FY25 earnings call — and how it ranks against sector peers.
ITC Ltd (Q3 FY25)
8,344 crore. Key concall takeaways from ITC Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
ITC Ltd (Q4 FY25)
Q4 FY25 Gross Revenue: ₹18,266 crore, up 9.2% YoY (Page 42) . Key concall takeaways from ITC Ltd's Q4 FY25 earnings call — and how it ranks against sector…
ITC Ltd (Q1 FY26)
20,911 crore, up 19.8% YoY (Page 41) . Key concall takeaways from ITC Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

Compare:vs ITC Ltd vs Hindustan Foods vs Godavari Bioref.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →